UNIC Athens has launched its new Evolve Lecture Series with an inaugural lecture by David Sinclair, Professor of Genetics at Harvard Medical School and one of the world’s foremost researchers on ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the most intriguing developments in regenerative medicine: epigenetic ...

Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...

A Boston company treated its first patient with a therapy intended to allow aging optic nerve cells to behave as though they were young again. The experimental treatment by Life Biosciences will ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...